Published in Lancet on January 25, 1992
Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest (1993) 0.84
Evidence of genetic and phenotypic heterogeneity in the Romano-Ward syndrome. J Med Genet (1993) 0.81
Doctor-patient communication: the Toronto consensus statement. BMJ (1991) 8.57
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet (2001) 6.96
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet (2000) 4.54
Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) (1998) 2.68
The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet (2001) 2.46
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation (1999) 2.17
Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet (2000) 2.14
Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury (2011) 2.07
Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet (2002) 1.91
The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr (1988) 1.90
Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development. Am J Hum Genet (2007) 1.88
A novel locus for an autosomal recessive hereditary spastic paraplegia (SPG35) maps to 16q21-q23. Neurology (2008) 1.81
Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet (1999) 1.80
Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke (1995) 1.77
Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet (1992) 1.72
Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med (1994) 1.71
Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet (1994) 1.58
Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol (1992) 1.58
Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair. Cardiology (2008) 1.57
A study of consanguinity in the Sultanate of Oman. Ann Hum Biol (2000) 1.49
Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am J Hum Genet (1994) 1.48
Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia. Clin Genet (2009) 1.46
Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion. Circulation (1996) 1.41
An oral history of changes in the Australian diet. Med J Aust (1993) 1.38
The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet (1997) 1.37
Rapid and safe termination of supraventricular tachycardia in children by adenosine. Lancet (1987) 1.35
Evidence-based recommendations for negative pressure wound therapy: treatment variables (pressure levels, wound filler and contact layer)--steps towards an international consensus. J Plast Reconstr Aesthet Surg (2011) 1.33
A gene for lymphedema-distichiasis maps to 16q24.3. Am J Hum Genet (1999) 1.32
TBX22 mutations are a frequent cause of cleft palate. J Med Genet (2004) 1.30
The natural history of Noonan syndrome: a long-term follow-up study. Arch Dis Child (2006) 1.29
Secondary glaucoma after paediatric cataract surgery. Br J Ophthalmol (2007) 1.25
Epilepsy monitoring and advice recorded: general practitioners' views, current practice and patients' preferences. Br J Gen Pract (1996) 1.25
A Noonan-like short stature syndrome with sparse hair. J Med Genet (1986) 1.22
The clinical spectrum of the Fraser syndrome: report of three new cases and review. J Med Genet (1987) 1.20
Abdominal ultrasound in Noonan syndrome: a study of 44 patients. Pediatr Radiol (1993) 1.17
Mannosidosis in two brothers: prolonged survival in the severe phenotype. Clin Genet (1982) 1.16
mtDNA mutations that cause optic neuropathy: how do we know? Am J Hum Genet (1998) 1.16
A computerized approach to dysmorphology. MD Comput (1987) 1.15
A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet (2000) 1.14
QT interval in twins. J Hum Hypertens (2000) 1.12
Radioimmunoassay of human muscle carbonic anhydrase III in dystrophic states. Clin Chim Acta (1982) 1.11
Cutis laxa and the Costello syndrome. J Med Genet (1993) 1.11
Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease. J Med Genet (1998) 1.10
Psychological profile of children with Noonan syndrome. Dev Med Child Neurol (2005) 1.10
The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet (2013) 1.10
Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet (2005) 1.10
CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart (2004) 1.08
Reduced penetrance in tuberous sclerosis. J Med Genet (1985) 1.07
Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet (2001) 1.07
The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am J Hum Genet (2001) 1.06
Characterization of human carbonic anhydrase III from skeletal muscle. Biochem Genet (1979) 1.05
Mutation detection in long QT syndrome: a comprehensive set of primers and PCR conditions. J Med Genet (2001) 1.03
Congenital fibrosis of the extraocular muscles associated with cortical dysplasia and maldevelopment of the basal ganglia. Ophthalmology (2001) 1.02
Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr (1998) 1.02
Ectrodactyly of hands and feet in a child with a complex translocation including 7q21.2. Am J Med Genet (1991) 1.01
Neural tube defects and congenital hydrocephalus in the Sultanate of Oman. J Trop Pediatr (1998) 1.00
Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation (1999) 1.00
Major factors determining the frequencies of hemoglobinopathies in Oman. Am J Med Genet (1997) 1.00
Sexual differentiation of rat liver carbonic anhydrase III. Biochim Biophys Acta (1983) 0.99
Moore-Federman syndrome and acromicric dysplasia: are they the same entity? J Med Genet (1989) 0.99
Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens (1994) 0.99
Evidence-based recommendations for the use of negative pressure wound therapy in chronic wounds: steps towards an international consensus. J Tissue Viability (2011) 0.98
Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J Med Genet (2003) 0.98
The clinical features of the Cohen syndrome: further case reports. J Med Genet (1985) 0.97
Location of mutations within the PKD2 gene influences clinical outcome. Kidney Int (2000) 0.97
Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study. J Inherit Metab Dis (2009) 0.97
Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart (2000) 0.97
Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens (1996) 0.97
Non-Mendelian transmission in a human developmental disorder: split hand/split foot. Am J Hum Genet (1994) 0.96
Immunoassay of carbonic anhydrase III in rat tissues. FEBS Lett (1982) 0.96
Guidelines for oral health care for long-stay patients and residents. Gerodontology (2000) 0.96
The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome. J Clin Endocrinol Metab (1996) 0.96
Myocardial disarray in Noonan syndrome. Br Heart J (1992) 0.95
Distribution of CAIII in fetal and adult human tissue. Biochem Genet (1980) 0.95
Congenital iris ectropion as an indicator of variant aniridia. Br J Ophthalmol (2006) 0.95
Energy dissipation in atomic force microscopy and atomic loss processes. Phys Rev Lett (2001) 0.94
Analysis of the population structure in Oman. Community Genet (1999) 0.93
A new classification system for primary lymphatic dysplasias based on phenotype. Clin Genet (2010) 0.92
Radioimmunoassay of carbonic anhydrase III in rat tissues. Biochem J (1984) 0.92
Mitochondrial complex deficiencies in a male with cardiomyopathy and 3-methylglutaconic aciduria. J Inherit Metab Dis (1995) 0.92
Silver syndrome is not linked to any of the previously established autosomal dominant hereditary spastic paraplegia loci. Am J Med Genet (2001) 0.91
Gestational related changes in the deep venous system of the lower limb on light reflection rheography in pregnancy and the puerperium. Clin Radiol (2007) 0.91
2 years' admissions to a regional child psychiatry unit. Br Med J (1967) 0.91
Epilepsy in general practice: patients' psychological symptoms and their perception of stigma. Br J Gen Pract (1996) 0.91
Further delineation of the DOOR syndrome. Clin Dysmorphol (2000) 0.91
Congenital trichomegaly, pigmentary retinal degeneration, and short stature. Am J Ophthalmol (1986) 0.90
Study of hemoglobinopathies in Oman through a national register. Saudi Med J (2000) 0.90
A family with craniofrontonasal dysplasia, and fragile site 12q13 segregating independently. Clin Genet (1986) 0.90
Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up. J Clin Endocrinol Metab (2001) 0.89
Common MCAD mutation in a healthy parent of two affected siblings. J Inherit Metab Dis (1995) 0.89
Congenital and genetic disorders in the Sultanate of Oman. First attempt to assess healthcare needs. J Community Genet (2014) 0.89
Neuronal properties of neuroectodermal tumors in vitro. Cancer Res (1981) 0.89
Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet (2007) 0.89